Cancer and heterogeneity of obesity: A potential contribution of brown fat

Future Oncology

Volumn 8, Issue 12, 2012, Pages 1537-1548

  Berstein, Lev M ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

browning of white fat; cancer; heterogeneity; mutations; obesity; tumor suppressors; types of hormonal carcinogenesis; white and brown fat

Indexed keywords

ADIPOCYTOKINE; BRCA1 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADIPOCYTE; BODY COMPOSITION; BODY FAT; BODY MASS; BROWN ADIPOSE TISSUE; CANCER RISK; CARCINOGENESIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GENE FUNCTION; GENETIC PREDISPOSITION; HORMONAL CARCINOGENESIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; NONHUMAN; OBESITY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; TUMOR SUPPRESSOR GENE; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, BROWN; BODY COMPOSITION; ENERGY METABOLISM; HUMANS; NEOPLASMS; OBESITY; RISK FACTORS;

EID: 84871252665     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.150     Document Type: Review

References (100)

1. Hill JO. Understanding and addressing the epidemic of obesity: An energy balance perspective. Endocr. Rev. 27, 750-761 (2006
2. Mitchell NS, Catenacci VA, Wyatt HR, Hill JO. Obesity: Overview of an epidemic. Psychiatr. Clin. North Am. 34, 717-732 (2011
3. Kurpad AV, Varadharajan KS, Aeberli I. The thin-fat phenotype and global metabolic disease risk. Curr. Opin. Clin. Nutr. Metab. Care 14, 542-547 (2011
4. Berstein LM. Cancer of hormone-dependent tissues in the frame of main non-communicable diseases. Aesculap, St. Peterburg, Russia. 180 (2009
5. Kaidar-Person O, Bar-Sela G, Person B. The two major epidemics of the twenty-first century: Obesity and cancer. Obes. Surg. 21, 1792-1797 (2011
6. Berstein LM. Macrosomy, Obesity and Cancer. Nova Science Publishers, NY, USA, 199 (1997
7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625-1638 (2003
8. Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579-591 (2004
9. Renehan AG, Tyson M, Egger M et al. Body-mass index and incidence of cancer: A systematic review and meta-Analysis of prospective observational studies. Lancet 371, 569-578 (2008
10. Renehan AG, Soerjomataram I, Tyson M et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int. J. Cancer 126, 692-702 (2010
11. Chen J. Multiple signal pathways in obesity-Associated cancer. Obes. Rev. 12, 1063-1070 (2011
12. Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: An inflammatory issue. Ann. N.Y. Acad. Sci. 1229, 45-52 (2011
13. Crosbie EJ, Roberts C, Qian W et al. Body mass index does not influence post-treatment survival in early stage endometrial cancer: Results from the MRC ASTEC trial. Eur. J. Cancer 48, 853-864 (2012
14. Karelis AD, St-Pierre DH, Conus F et al. Metabolic and body composition factors in subgroups of obesity: What do we know? J. Clin. Endocrinol. Metab. 89, 2569-2575 (2004
15. Bershtein LM, Kovalenko IG. 'Metabolically healthy' people with obesity and metabolic signs of obesity in normal weight people: What is behind of it? Probl. Endocrinol. (Mos.) 3, 47-51 (2010
16. Yang Y, Dong J, Sun K et al. Obesity and incidence of lung cancer: A meta-Analysis. Int. J. Cancer doi:10.1002/ijc.27719 (2012) (Epub ahead of print
17. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health 121, 492-496 (2007
18. Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer 11, 886-895 (2011
19. Liu LN, Miaskowski C, Wang JS et al. Accuracy of body mass index to determine obesity in women with breast cancer: An observational study of Taiwanese sample. Int. J. Nurs. Stud. 47, 994-1000 (2010
20. Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscle. Physiol. Rev. 91, 1447-1531 (2011
21. Hittel DS, Berggren JR, Shearer J et al. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 58, 30-38 (2009
22. Zhang C, McFarlane C, Lokireddy S et al. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia 55, 183-193 (2012
23. Murphy KT, Chee A, Gleeson BG et al. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R716-R726 (2011
24. Prado CM, Lieffers JR, McCargar LJ et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol. 9(7), 629-635 (2008
25. Stults-Kolehmainen MA, Stanforth PR, Bartholomew JB. Fat in android, trunk, and peripheral regions varies by ethnicity and race in college aged women. Obesity (Silver Spring) 20, 660-665 (2012
26. Petrek JA, Peters M, Cirrincione C et al. Is body fat topography a risk factor for breast cancer? Ann. Intern. Med. 118, 356-362 (1993
27. Pischon T, Nöthlings U, Boeing H. Obesity and cancer. Proc. Nutr. Soc. 67, 128-145 (2008
28. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548-2556 (2004
29. Berstein LM. Hormones of adipose tissue (adipocytokines): Ontogenetic and oncologic aspects. Adv. Gerontol. 16, 51-64 (2005
30. Blüher M. Adipose tissue dysfunction in obesity. Exp. Clin. Endocrinol. Diabetes 117, 241-250 (2009
31. Sung MK, Yeon JY, Park SY et al. Obesity-induced metabolic stresses in breast and colon cancer. Ann. N.Y. Acad. Sci. 1229, 61-68 (2011
32. Dilman VM, Berstein LM, Ostroumova MN et al. Metabolic immunodepression and metabolic immunotherapy: An attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology 39, 13-19 (1982
33. von Gruenigen VE, Courneya KS, Gibbons HE et al. Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: A randomized trial. Gynecol. Oncol. 109, 19-26 (2008
34. Tokunaga M, Hiki N, Fukunaga T et al. Effect of individual fat areas on early surgical outcomes after open gastrectomy for gastric cancer. Br. J. Surg. 96, 496-500 (2009
35. Guiu B, Petit JM, Bonnetain F et al. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut 59, 341-347 (2010
36. Gomez-Santos C, Hernandez-Morante JJ, Margareto J et al. Profile of adipose tissue gene expression in premenopausal and postmenopausal women: Site-Specific differences. Menopause 18, 675-684 (2011
37. Kilpeläinen TO, Zillikens MC, Stančákova A et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat. Genet. 43, 753-760 (2011
38. Andrade FH, Figueiroa FC, Bersano PR et al. Malignant mammary tumor in female dogs: Environmental contaminants. Diagn. Pathol. 5, 45-47 (2010
39. Berstein LM, Kovalevskij AY, Poroshina TE et al. Signs of proinflammatory genotoxic switch (adipogenotoxicosis) in mammary fat of breast cancer patients: Role of menopausal status, estrogens and hyperglycemia. Int. J. Cancer 121, 514-519 (2007
40. Bershtein LM, Kovalevskǐ AIu, Poroshina TE et al. Progenotoxic shift in mammary adipose tissue (adipogenotoxicosis): Association with clinical and biological characteristics of breast cancer. Vopr. Onkol. 54, 294-302 (2008
41. Iyengar P, Espina V, Williams TW et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J. Clin. Invest. 115, 1163-1176 (2005
42. Carter JC, Church FC. Mature breast adipocytes promote breast cancer cell motility. Exp. Mol. Pathol. 92(3), 312-317 (2012
43. D'Esposito V, Passaretti F, Hammarstedt A et al. Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro. Diabetologia 55(10), 2811-22 (2012
44. Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism 50, 1499-1504 (2001
45. Calori G, Lattuada G, Piemonti L et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: The Cremona Study. Diabetes Care 34, 210-215 (2011
46. Noppa H, Bengtsson C, Isaksson B, Smith U. Adipose tissue cellularity in adulthood and its relation to childhood obesity. Int. J. Obes. 4, 253-263 (1980
47. Arner E, Westermark PO, Spalding KL et al. Adipocyte turnover: Relevance to human adipose tissue morphology. Diabetes 59, 105-109 (2010
48. Park KW, Halperin DS, Tontonoz P. Before they were fat: Adipocyte progenitors. Cell Metab. 8, 454-457 (2008
49. Ahfeldt T, Schinzel RT, Lee YK et al. Programming human pluripotent stem cells into white and brown adipocytes. Nat. Cell Biol. 14, 209-219 (2012
50. Zhang Y, Bellows CF, Kolonin MG. Adipose tissue-derived progenitor cells and cancer. World J. Stem Cells 2, 103-113 (2010
51. Bellows CF, Zhang Y, Chen J et al. Circulation of progenitor cells in obese and lean colorectal cancer patients. Cancer Epidemiol. Biomarkers Prev. 20, 2461-2468 (2011
52. Medici D, Kalluri R. Endothelial- mesenchymal transition and its contribution to the emergence of stem cell phenotype. Semin. Cancer. Biol. 22(5-6), 379-384. (2012
53. Seale P, Bjork B, Yang W et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454, 961-967 (2008
54. Ricquier D. Biology of brown adipose tissue: View from the chair. Int. J. Obes. (Lond.) (SUPPL1), S3-S6 (2010
55. Richard D, Picard F. Brown fat biology and thermogenesis. Front. Biosci. 16, 1233-1260 (2011
56. Frontini A, Cinti S. Distribution and development of brown adipocytes in the murine and human adipose organ. Cell Metab. 11, 253-256 (2010
57. Chen YI, Cypess AM, Sass CA et al. Anatomical and functional assessment of brown adipose tissue by magnetic resonance imaging. Obesity (Silver Spring) 20(7), 1519-1526 (2012
58. Cypess AM, Lehman S, Williams G et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509-1517 (2009
59. Ouellet V, Routhier-Labadie A, Bellemare W et al. Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. J. Clin. Endocrinol. Metab. 96, 192-199 (2011
60. Townsend KL, Tseng YH. Brown adipose tissue. Recent insights into development, metabolic function and therapeutic potential. Adipocyte 1, 13-24 (2012
61. Cinti S. Between brown and white: Novel aspects of adipocyte differentiation. Ann. Med. 43, 104-115 (2011
62. Wang F, Liu H, Blanton WP et al. Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochem. J. 425, 71-83 (2009
63. Waldén TB, Hansen IR, Timmons JA et al. Recruited vs. nonrecruited molecular signatures of brown, 'brite,' and white adipose tissues. Am. J. Physiol. Endocrinol. Metab. 302(1), E19-E31 (2012
64. Wu J, Boström P, Sparks LM et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150(2), 366-76 (2012
65. Fisher FM, Kleiner S, Douris N et al. FGF21 regulates PGC-1a and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 26, 271-281 (2012
66. Ohno H, Shinoda K, Spiegelman BM et al. PPARg agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab. 5, 395-404 (2012
67. Vitali A, Murano I, Zingaretti MC et al. The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes. J. Lipid Res. 53, 619-629 (2012
68. Vegiopoulos A, Müller-Decker K, Strzoda D et al. Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. Science 328, 1158-1161 (2010
69. Fliers E, Boelen A. Type 2 deiodinase and brown fat: The heat is on - or off. Endocrinology 151, 4087-4089 (2010
70. Cypess AM, Kahn CR. Brown fat as a therapy for obesity and diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 17, 143-149 (2010
71. Whittle AJ, López M, Vidal-Puig A. Using brown adipose tissue to treat obesity - The central issue. Trends Mol. Med. 17, 405-411 (2011
72. Furlong MA, Fanburg-Smith JC, Miettinen M. The morphologic spectrum of hibernoma: A clinicopathologic study of 170 cases. Am. J. Surg. Pathol. 25(6), 809-814 (2001
73. Nord KH, Magnusson L, Isaksson M et al. Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernoma. Proc. Natl Acad. Sci. USA 107(49), 21122-21127 (2010
74. Russell AP, Crisan M, Léger B et al. Brown adipocyte progenitor population is modified in obese and diabetic skeletal muscle. Int. J. Obes. (Lond.) 36, 155-158 (2012
75. Nitzki F, Zibat A, Frommhold A et al. Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice. Oncogene 30(43), 4428-4436 (2011
76. Lee P, Zhao JT, Swarbrick MM et al. High prevalence of brown adipose tissue in adult humans. J. Clin. Endocrinol. Metab. 96, 2450-2455 (2011
77. Huang YC, Chen TB, Hsu CC et al. The relationship between brown adipose tissue activity and neoplastic status: An (18)F-FDG PET/CT study in the tropics. Lipids Health Dis. 10, 238-243 (2011
78. Aukema TS, Vogel WV, Hoefnagel CA, Valdés Olmos RA. Prevention of brown adipose tissue activation in 18F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy. J. Nucl. Med. Technol. 38, 24-27 (2010
79. Rousseau C, Bourbouloux E, Campion L et al. Brown fat in breast cancer patients: Analysis of serial (18)F-FDG PET/CT scans. Eur. J. Nucl. Med. Mol. Imaging 33, 785-791 (2006
80. Ortega-Molina A, Efeyan A, Lopez- Guadamillas E et al. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab. 15, 382-394 (2012
81. Jones LP, Buelto D, Tago E, Owusu-boaltey KE. Abnomal mammary adipose tissue environment of Brca1 mutant mice show a persistent deposition of highly vascularized multilocular adipocytes. J. Cancer Sci. Ther. S2, 1-6 (2011
82. Shakya R, Szabolcs M, McCarthy E et al. The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression. Proc. Natl Acad. Sci. USA 105(19), 7040-7045 (2008
83. de Moura MB, dos Santos LS, Van Houten B. Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ. Mol. Mutagen. 51, 391-405 (2010
84. Paz-Filho G, Lim EL, Wong ML, Licinio J. Associations between adipokines and obesity-related cancer. Front. Biosci. 16, 1634-1650 (2011
85. Santen R, Cavalieri E, Rogan E et al. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann. N.Y. Acad. Sci. 1155, 132-140 (2009
86. Berstein LM. Role of endocrine-genotoxic switchings in cancer and other human diseases: Basic triad. Adv. Exp. Med. Biol. 630, 35-51 (2008
87. Bansal N, Yendluri V, Wenham RM. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control 16, 8-13 (2009
88. Kunkel SD, Elmore CJ, Bongers KS et al. Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. Plos One 7(6), e39332 (2012
89. Wu B, Wang X, Chi ZF et al. Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway. Arch. Pharm. Res. 35(3), 543-548 (2012
90. Foulkes WD. Clinically relevant biology of hereditary breast cancer. Semin. Oncol. 34(5), 379-383 (2007
91. Rosen EM, Fan S, Isaacs C. BRCA1 in hormonal carcinogenesis: Basic and clinical research. Endocr. Relat. Cancer 12, 533-548 (2005
92. Berstein LM. Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesis. Future Oncol. 4, 23-39 (2008
93. Dellas A, Jundt G, Sartorius G et al. Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas. Clin. Cancer Res. 15(7), 2456-2462 (2009
94. Møller P, Maehle L, Vabø A et al. Age-Specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway. Clin Genet. doi:10.1111/j.1399-0004.2012.01855.x (2012) (Epub ahead of print
95. Cannon B, Nedergaard J. Cell biology: Neither brown nor white. Nature 488, 286-287 (2012
96. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocrinol. Metab. 97, 2482-2488 (2012
97. Ortega FB, Lee DC, Katzmarzyk PT et al. The intriguing metabolically healthy but obese phenotype: Cardiovascular prognosis and role of fitness. Eur. Heart J. doi:10.1093/eurheartj/ ehs174 (2012) (Epub ahead of print
98. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol. 15, 10-17 (1983
99. Scata KA, El-Deiry WS. p53, BRCA1 and breast cancer chemoresistance. Adv. Exp. Med. Biol. 608, 70-86 (2007
100. Brunet J, Vazquez-Martin A, Colomer R et al. BRCA1 and acetyl-coA carboxylase: The metabolic syndrome of breast cancer. Mol. Carcinog. 47, 157-163 (2008